Santen, Glaukos sign distribution agreement for MicroShunt in US

By NS Medical Staff Writer

29 Apr 19

Santen Pharmaceutical’s US subsidiary and Glaukos have entered into collaboration and distribution agreement for exclusive distribution of MicroShunt…

DevicesOphthalmic

Oculos and Optceutics join forces to expand services for ophthalmic innovators

By NS Medical Staff Writer

29 Apr 19

Oculos, a vertically-integrated ophthalmic R&D organization, and Optceutics, an expert in ophthalmic R&D, have signed a co-promotion agreement…

DevicesOphthalmic

Visioneering, Lambda-X develop software to show NaturalVue contact lens power profile

By NS Medical Staff Writer

22 Apr 19

American medical devices company Visioneering Technologies (VTI) and ophthalmic products developer Lambda-X have developed customized software that can…

DevicesOphthalmic

Huawei introduces new technology to detect early visual impairment in children

By NS Medical Staff Writer

17 Apr 19

Huawei has partnered with medical research bodies IIS Aragon and DIVE Medical to launch Track AI, an AI-powered…

DevicesOphthalmic

LumiThera starts enrolling patients for LIGHTSITE II study in Europe to treat AMD

By NS Medical Staff Writer

12 Apr 19

LumiThera, a company developing treatment for ocular diseases, has started enrolling patients for LIGHTSITE II, a multi-center, clinical…

DevicesOphthalmic

Eye care firm Alcon launches as independent firm

By NS Medical Staff Writer

09 Apr 19

Eye care firm Alcon has been separated from Novartis and launched as an independent, publicly traded company to…

DevicesOphthalmic

How EyeQue can be used at home for vision tests

By Anjuman Rahman

08 Apr 19

EyeQue is a device that lets people use their smartphones as part of an at home vision test…

Patient Care DevicesPatient Care MonitoringDiagnostic Devices

Lantheus partners with Cerevast for new eye care application using Microbubbles

By NS Medical Staff Writer

03 Apr 19

Lantheus, the parent company of Lantheus Medical Imaging, has collaborated with Cerevast Medical for treating retinal vein occlusion…

DevicesOphthalmic

Johnson & Johnson Vision’s antihistamine-releasing contact lenses shows positive phase 3 results

By NS Medical Staff Writer

27 Mar 19

Johnson & Johnson Vision has announced positive results from two phase 3 clinical studies evaluating investigational antihistamine-releasing contact…

DevicesOphthalmic

Novartis meets key conditions for spin-off of Alcon eye care division

By NS Medical Staff Writer

25 Mar 19

Swiss drugmaker Novartis has announced that it is planning to complete the 100% separation of its eye care…

DevicesOphthalmic